EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Investing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-5.17 Cr | ₹-13 Cr | ₹-16 Cr | ₹-17 Cr | ₹-12 Cr |
What is the latest Cash Flow from Investing Activities ratio of EVEREST ORGANICS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-5.17 Cr |
| Mar2024 | ₹-13 Cr |
| Mar2023 | ₹-16 Cr |
| Mar2022 | ₹-17 Cr |
| Mar2021 | ₹-12 Cr |
How is Cash Flow from Investing Activities of EVEREST ORGANICS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-5.17 Cr | Negative | |
| Mar2024 | ₹-13 Cr | Negative | |
| Mar2023 | ₹-16 Cr | Negative | |
| Mar2022 | ₹-17 Cr | Negative | |
| Mar2021 | ₹-12 Cr | - | |
Compare Cash Flow from Investing Activities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹424.0 Cr | -12.6% | -9.4% | 72.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -12.6% |
-9.4% |
72.3% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses